Rinie Geenen

Prof. Dr. Rinie Geenen


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Best Practice & Research Clinical Rheumatology
Verified
Journal Article
Closed access
RGRinie Geenen
Rinie Geenen
SNStanton Newman
Stanton Newman
EBErcolie R. Bossema
Ercolie R. Bossema
JVJohanna E. Vriezekolk
Johanna E. Vriezekolk
PBPaul A. Boelen
Paul A. Boelen

9 July 2014 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
EGEllen Generaal
Ellen Generaal
NVNicole Vogelzangs
Nicole Vogelzangs
GMGary Macfarlane
Gary Macfarlane
RGRinie Geenen
Rinie Geenen
JSJohannes H Smit
Johannes H Smit
JDJoost Dekker
Joost Dekker
Studies on hypothalamic-pituitary-adrenal axis (HPA-axis) function amongst patients with chronic pain show equivocal results and well-controlled cohort studies are rare in this field. The goal of our study was to examine whether HPA-axis dysfunction is associated with the presence and the severity of chronic multi-site musculoskeletal pain.

1 November 2019 in Rheumatology
Verified
Journal Article
Open access
RGRinie Geenen
Rinie Geenen
EDEmma Dures
Emma Dures
Fatigue in RA is prevalent, intrusive and disabling. We propose a network model of fatigue encompassing multiple and mutually interacting biological, psychological and social factors. Guided by this model, we reviewed the literature to offer a comprehensive overview of factors that have been associated with fatigue in RA. Six categories of variables were found: physical functioning, psychological functioning, medical status, comorbidities and symptoms, biographical variables and miscellaneous variables. We then systematically reviewed associations between fatigue and factors commonly addressed by rheumatology health professionals. Correlations of fatigue with physical disability, poor mental well-being, pain, sleep disturbance and depression and anxiety were ∼0.50. Mostly these correlations remained significant in multivariate analyses, suggesting partly independent influences on fatigue and differences between individuals. These findings indicate the importance of research into individual-specific networks of biopsychosocial factors that maintain fatigue and tailored interventions that target the influencing factors most relevant to that person.

17 May 2023 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
APAna M Pinto
Ana M Pinto
MLMariana Luís
Mariana Luís
RGRinie Geenen
Rinie Geenen
FPFilipe Palavra
Filipe Palavra
MLMark A. Lumley
Mark A. Lumley
JSJosé A.P. da Silva
José A.P. da Silva

1 January 2012 in Journal of Psychosomatic Research
Verified
Journal Article
Closed access
RGRinie Geenen
Rinie Geenen
LLLinda van Ooijen-Van der Linden
Linda van Ooijen-Van der Linden
MLMark A. Lumley
Mark A. Lumley
JBJohannes W.J. Bijlsma
Johannes W.J. Bijlsma
HMHenriët van Middendorp
Henriët van Middendorp

21 August 2023 in RMD Open
Verified
Journal Article
Open access
PDF file
ESEduardo Santos
Eduardo Santos
BFBayram Farisogullari
Bayram Farisogullari
EDEmma Dures
Emma Dures
RGRinie Geenen
Rinie Geenen
PMPedro M Machado
Pedro M Machado
Objective To identify the best evidence on the efficacy of non-pharmacological interventions in reducing fatigue in people with inflammatory rheumatic and musculoskeletal diseases (I-RMDs) and to summarise their safety in the identified studies to inform European Alliance of Associations for Rheumatology recommendations for the management of fatigue in people with I-RMDs. Methods Systematic review of randomised controlled trials (RCTs) including adults with I-RMDs conducted according to the Cochrane Handbook. Search strategy ran in Medline, Embase, Cochrane Library, CINAHL Complete, PEDro, OTseeker and PsycINFO. Assessment of risk of bias, data extraction and synthesis were performed by two reviewers independently. Data were pooled in meta-analyses. Results From a total of 4150 records, 454 were selected for full-text review, 82 fulfilled the inclusion criteria and 55 RCTs were included in meta-analyses. Physical activity or exercise was efficacious in reducing fatigue in rheumatoid arthritis (RA) (standardised mean differences (SMD)=−0.23, 95% CI=−0.37 to −0.1), systemic lupus erythematosus (SLE) (SMD=−0.54, 95% CI=−1.07 to −0.01) and spondyloarthritis (SMD=−0.94, 95% CI=−1.23 to −0.66); reduction of fatigue was not significant in Sjögren’s syndrome (SMD=−0.83, 95% CI=−2.13 to 0.47) and systemic sclerosis (SMD=−0.66, 95% CI=−1.33 to 0.02). Psychoeducational interventions were efficacious in reducing fatigue in RA (SMD=−0.32, 95% CI=−0.48 to −0.16), but not in SLE (SMD=−0.19, 95% CI=−0.46 to 0.09). Follow-up models in consultations (SMD=−0.05, 95% CI=−0.29 to 0.20) and multicomponent interventions (SMD=−0.20, 95% CI=−0.53 to 0.14) did not show significant reductions of fatigue in RA. The results of RCTs not included in the meta-analysis suggest that several other non-pharmacological interventions may provide a reduction of fatigue, with reassuring safety results. Conclusions Physica activity or exercise and psychoeducational interventions are efficacious and safe for managing fatigue in people with I-RMDs.